Evidence map›Paper›PMID 34058063›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2022

Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney.

Claire E Sexton, Kaarin J Anstey, Filippo Baldacci, C J Barnum, Anna M Barron, Kaj Blennow, Henry Brodaty, Samantha Burnham, Fanny M Elahi, Jürgen Götz and 25 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Co-design of dementia prevention program for Aboriginal Australians (DAMPAA).Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Claire E SextonAlzheimer's Association, Chicago, Illinois, USA.ORCID 0000-0002-3846-2986
Kaarin J AnsteyUniversity of New South Wales and Neuroscience Research, Sydney, NSW, Australia.
Filippo BaldacciUnit of Neurology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
C J BarnumINmune Bio Inc., La Jolla, CA, USA.
Anna M BarronLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Henry BrodatyCentre for Healthy Brain Ageing, University of New South Wales, Sydney, NSW, Australia.
Samantha BurnhamCSIRO Health & Biosecurity, The Australian e-Health Research Centre, Parkville, VIC, Australia.
Fanny M ElahiMemory and Aging Center, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
Jürgen GötzClem Jones Centre for Ageing Dementia Research (CJCADR), Queensland Brain Institute (QBI), The University of Queensland, St Lucia Campus (Brisbane), Brisbane, QLD, Australia.
Yun-Hee JeonThe University of Sydney, Sydney, NSW, Australia.
Maya Koronyo-HamaouiDepartments of Neurosurgery and Biomedical Sciences, Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Susan M LandauUniversity of California Berkeley, Berkeley, California, USA.
Nicola T LautenschlagerAcademic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.
Simon M LawsCollaborative Genomics and Translation Group, Edith Cowan University, Joondalup, WA, Australia.
Darren M LipnickiCentre for Healthy Brain Ageing, University of New South Wales, Sydney, NSW, Australia.
Hanzhang LuDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Colin L MastersThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, Australia.
Wendy MoyleMenzies Health Institute Queensland, Griffith University, Griffith, QLD, Australia.
Akinori NakamuraDepartment of Biomarker Research, National Center for Geriatrics and Gerontology, Obu, Japan.
Giulio Maria PasinettiDepartment of Neurology, Icahn School of Medicine at Mount Sinai (ISSMS), New York, New York, USA.
Naren RaoDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Christopher RoweThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, Australia.
Perminder S SachdevCentre for Healthy Brain Ageing, University of New South Wales, Sydney, NSW, Australia.
Peter R SchofieldNeuroscience Research Australia, Sydney and School of Medical Sciences, UNSW Sydney, Sydney, NSW, Australia.
Einar M SigurdssonDepartments of Neuroscience and Physiology, and Psychiatry, Neuroscience Institute, New York University Grossman School of Medicine, New York, New York, USA.
Kate SmithCentre for Aboriginal Medical and Dental Health, University of Western Australia, Crawley, WA, Australia.
Velandai SrikanthPeninsula Clinical School, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Cassandra SzoekeUniversity of Melbourne, VIC, Australia.
Malú G TanseyDepartments of Neuroscience and Neurology, Center for Translational Research in Neurodegenerative Disease, Normal Fixel Center for Neurological Diseases, University of Florida College of Medicine, Gainesville, Florida, USA.
Rachel WhitmerDepartment of Public Health Sciences, University of California, Davis, Davis, California, USA.
Donna WilcockSanders-Brown Center on Aging and Department of Physiology, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Tien Y WongSingapore Eye Research Institute, Singapore National Eye Center, Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.
Lisa J BainIndependent Science Writer, Elverson, Pennsylvania, USA.
Maria C CarrilloAlzheimer's Association, Chicago, Illinois, USA.

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
US POINTER Neuroimaging Ancillary StudyR01AG062689 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI LANDAU, SUSAN M · 2019 to 2025
$47.3M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI OANH L MEYER · 2021 to 2026
$25.2M
Pasinetti: Project 3; Role of Microbiome in Promotion of Cognitive and Psychological Resilience (Faith)P50AT008661 · NCCIH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DIXON, RICHARD A, PASINETTI, GIULIO MARIA · 2015 to 2019
$11.2M
Research Supplement to Promote Diversity in Health-Related ResearchR01AG032611 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Einar M Sigurdsson · 2008 to 2026
$9.7M
Epitope-Specific Targeting of Tau Aggregates.R01NS077239 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Einar M Sigurdsson · 2011 to 2026
$7.9M
A global epidemiology of cognitive impairment and dementia due to Alzheimer's disease and related disorders: the COSMIC CollaborationR01AG057531 · NIA · UNIVERSITY OF NEW SOUTH WALES · PI Perminder S SACHDEV · 2023 to 2026
$5.9M
Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the RetinaR01AG055865 · NIA · CEDARS-SINAI MEDICAL CENTER · PI Maya Koronyo-Hamaoui · 2018 to 2026
$4.9M
Mechanisms of Alzheimer's Disease Progression in the Aging BrainR01AG062542 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI JAGUST, WILLIAM J. · 2019 to 2023
$4.2M
Inflammation and Renin-Angiotensin System Dysfunction as risk factors for ADRF1AG051514 · NIA · EMORY UNIVERSITY · PI NORRIS, CHRISTOPHER MARK, WALKER, LARY C · 2015 to 2017
$3.6M
Novel imaging and endothelial biomarkers of small vessel cerebrovascular diseaseUH3NS100608 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DECARLI, CHARLES, KRAMER, JOEL H · 2018 to 2020
$3.5M
Development of MRI microvascular biomarkers in cognitive impairment and dementiaUH3NS100588 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ALBERT, MARILYN S., LU, HANZHANG · 2018 to 2020
$3.5M
CSRD VA IK2 CX002180NCCIH NIH HHS P50 AT008661NIA NIH HHS P30 AG072972NIA NIH HHS R01 AG032611NIA NIH HHS R01 AG055865NIA NIH HHS R01 AG056478NIA NIH HHS R01 AG057531NIA NIH HHS R01 AG062542NIA NIH HHS R01 AG062689NIA NIH HHS R01 AG064792NIA NIH HHS R21 AG058282NIA NIH HHS R21 AG059391NIA NIH HHS RF1 AG051514NIA NIH HHS RF1 AG057247NIA NIH HHS RF1 AG057531NIA NIH HHS RF1 AG057754NIA NIH HHS U19 AG024904NIH HHS R01 AG064792NIH HHS UH3 NS100588NINDS NIH HHS R01 NS077239NINDS NIH HHS R01 NS092122NINDS NIH HHS R01 NS097722NINDS NIH HHS R01 NS120488NINDS NIH HHS RF1 NS120488NINDS NIH HHS RF1 NS128800NINDS NIH HHS UH3 NS100588NINDS NIH HHS UH3 NS100606NINDS NIH HHS UH3 NS100608
6 · The paper itself

Abstract

The Alzheimer's Association International Conference held its sixth Satellite Symposium in Sydney, Australia in 2019, highlighting the leadership of Australian researchers in advancing the understanding of and treatment developments for Alzheimer's disease (AD) and other dementias. This leadership includes the Australian Imaging, Biomarker, and Lifestyle Flagship Study of Ageing (AIBL), which has fueled the identification and development of many biomarkers and novel therapeutics. Two multimodal lifestyle intervention studies have been launched in Australia; and Australian researchers have played leadership roles in other global studies in diverse populations. Australian researchers have also played an instrumental role in efforts to understand mechanisms underlying vascular contributions to cognitive impairment and dementia; and through the Women's Healthy Aging Project have elucidated hormonal and other factors that contribute to the increased risk of AD in women. Alleviating the behavioral and psychological symptoms of dementia has also been a strong research and clinical focus in Australia.

Indexed as

Biomedical ResearchDisease ProgressionProdromal SymptomsAgingAlzheimer DiseaseAustraliaBiomarkersCognitive DysfunctionHumansLife StylePositron-Emission TomographyBiomarkersAlzheimer'sbehavioral symptomsbiomarkersdementiaprevention

Identifiers

PMID34058063
PMCPMC9396711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.